Tuesday, February 21, 2012 - 08:00 to 09:15

GHD online invites experts to join a week-long panel discussion on managing second line anti-TB drugs (SLD). Starting on 20 February, GHD invites you to ask questions and share your experiences on this topic with a group of panelists led by Dr. Masoud Dara, Team Leader of the Tuberculosis Programme in the Division of Communicable Diseases, Health Security & Environment at WHO Europe, and the GHDonline Moderator:

- Dr Lucica Ditiu, Executive secretary StopTB Partnership
- Dr Kaspars Lunte, Team Leader MDR TB supply WHO-Global Drug Facility
- Dr Ernesto Jaramillo, WHO HQ, policy guidance and palliative care
- Dr Andrei Zagorski, Management Sciences for Health, Drug management

Portfolio Manager of the Global Fund Mrs. Sandra Irbe will also join the discussion.

Initial questions include:

- What issues do you face with the supply of SLD? Are there big time lags between order and delivery for example?
- Have you been affected by price increases of SLD and what is the impact on your work?
- How are you funding drug procurement for MDR-TB?
- What does the cancellation of Round 11 mean to you, your program, and for the population you care for?
- Are you applying to the TFM and if so how do you prioritize funding request?

Join the discussion